When we talk about complications, we need to talk about “Risk” #TalkAboutComplications
It’s hard not to have seen the recent Twitter and blog campaign that came about as the result of Grumpy Pumper’s diagnosis of a foot […]
Diabetes
#DIYAPS use in the UK – A Snapshot
In the UK, at least 82 people (as of the date of publishing) are using DIY APS systems to manage their diabetes. Of these, the majority are using AndroidAPS.
A month with Medtrum’s A6 CGM
With two sensors now used and a month of data captured, I felt it was time for further feedback on the newest CGM system on […]
Is Hba1C a poor yardstick for determining access to new T1D treatments in the real world
If you’ve ever looked at a clinical trials document for a type 1 treatment, you’ll nearly always spot two things. Reduction in Hba1C is a […]
Rise of the Machines – Technology and “patient-driven” innovation in the treatment of diabetes #T1DRoM
On Saturday, if you didn’t know already, we ran a first for the UK. A day’s conference focusing on Diabetes Technology, and majoring on “Patient […]
Fiasp – going off-label. Being intentionally non-compliant!
Warning: What is discussed in this post is not recommended by the manufacturer and not aligned with the European Medicines Agency sign off for Fiasp. […]
Carb Ratio variation – a side effect of Fiasp or something else?
One of the things that I’ve previously noted is that I’ve seen a fair amount of variability in using Fiasp, both in insulin sensitivity and […]
Diabetes Technologies that never took off. Whatever happened to the “Sprinkler Needle”?
One of the biggest difficulties people with Diabetes have with MDI is timing insulin delivery. This isn’t helped by advice received from HCPs which tends […]
Fiasp – some further observations… Or why an artificial pancreas can’t do everything!
I’ve written about the various curveballs that Fiasp has thrown at me on multiple occasions, and for the past few weeks I’ve continued to observe […]
Analyzing the output of the continuous monitoring survey – some thoughts on the data… #wearenotwaiting
Earlier this week I published the first set of results of the survey of CGM and Libre users that I undertook last year. There was […]